Clinical Pharmacology & Biopharmaceutics
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 1089
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Nanomembrane microtubular devices for on- and off-chip biomedical research and development
6th European Biopharma Congress
Oliver G Schmidt
Institute for Integrative Nanosciences, Germany
Keynote: Clin Pharmacol Biopharm
DOI:
Abstract
Nanomembranes are thin, flexible, and transferable and can be shaped into 3D microtubular devices. This makes them attractive for a broad range of applications and scientific research fields ranging from novel hybrid heterostructure devices to ultracompact 3D systems both on and off the chip. If nanomembranes are differentially strained they deform themselves and roll-up into microtubular structures upon release from their mother substrate. Rolled-up nanomembranes can be exploited to rigorously compact electronic circuitry into microtubular systems. As rolled-up microtubes can be easily tuned into the size range of single cells, they are perfectly suited to study single cell behaviour in sensitive yet fully integrative lab-in-a-tube systems. As off-chip components they address exciting environmental and biomedical applications. For instance, if magnetic tubes or helices are combined with spermatozoa, such biomagnetic cellular organisms offer new perspectives towards assisted reproduction technologies and drug delivery protocols. However, while such micrometer sized robots show great potential for medical applications they face equally big challenges when considering in-vivo operation.Biography
Oliver G Schmidt is the Director of the Institute for Integrative Nanosciences at the Leibniz IFW Dresden, Germany. His interests bridge across several disciplines, ranging from nanomaterials and nanoelectronics to microfluidics, microrobotics and biomedical applications. He has received several awards: Otto-Hahn Medal from the Max- Planck-Society in 2000, Philip-Morris Research Award in 2002, Carus-Medal from the German Academy of Natural Scientists Leopoldina in 2005, and International Dresden Barkhausen Award in 2013. Most recently, he was awarded the Gottfried Wilhelm Leibniz-Prize 2018 of the German Research Foundation. The Leibniz-Prize is the most important research award in Germany for his outstanding work in the investigation, manufacturing and innovative application of functional nanostructures.
E-mail: schmidt@ifw-dresden.de
